Literature DB >> 27381585

Development and evaluation of PLGA polymer based nanoparticles of quercetin.

Md Khalid Anwer1, Mohammed A Al-Mansoor2, Shahid Jamil2, Ramadan Al-Shdefat2, Mohammad Nazam Ansari3, Faiyaz Shakeel4.   

Abstract

Quercetin is the most abundant antioxidant found in the human diet. Low aqueous solubility of quercetin limits its bioavailability and hence therapeutic effects. Therefore, the aim of the present study was to develop a poly lactide-co-glycolic acid (PLGA) polymer based nanoparticles of quercetin with a view to improve its aqueous solubility and examine the effect on its antioxidant and diuretic properties. Nanoparticles of quercetin were developed by single emulsion-solvent evaporation technique and evaluated in vitro for differential scanning calorimetry (DSC), Fourier transforms infra-red (FTIR) spectroscopy, particle size, polydispersity index and drug entrapment efficiency. Among the five different formulations (F1, F2, F3, F4 and F5), F2 and F3 were optimized with an average particle size of 189nm and 186nm and high entrapment values of 86.48%, 83.71%, respectively. SEM images of confirmed that prepared nanoparticles were spherical in shape with a smooth surface. In vitro release and anti-oxidant activity confirmed significant results. Furthermore, its in vivo diuretic activity was much better as compared to pure quercetin. The overall results suggest that PLGA polymer based nanoparticle could be a potential option for quercetin delivery.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diuretic activity; PLGA nanoparticle; Quercetin

Mesh:

Substances:

Year:  2016        PMID: 27381585     DOI: 10.1016/j.ijbiomac.2016.07.002

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  11 in total

1.  Abemaciclib-loaded ethylcellulose based nanosponges for sustained cytotoxicity against MCF-7 and MDA-MB-231 human breast cancer cells lines.

Authors:  Md Khalid Anwer; Farhat Fatima; Mohammed Muqtader Ahmed; Mohammed F Aldawsari; Amer S Alali; Mohd Abul Kalam; Aws Alshamsan; Musaed Alkholief; Abdul Malik; Alanazi Az; Ramadan Al-Shdefat
Journal:  Saudi Pharm J       Date:  2022-04-06       Impact factor: 4.562

2.  Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect.

Authors:  Md Khalid Anwer; Muqtader Mohammad; Muzaffar Iqbal; Mohd Nazam Ansari; Essam Ezzeldin; Farhat Fatima; Saad M Alshahrani; Mohammed F Aldawsari; Ahmed Alalaiwe; Aiman A Alzahrani; Abdullah M Aldayel
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

3.  Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome.

Authors:  Md K Anwer; Ramadan Al-Shdefat; Essam Ezzeldin; Saad M Alshahrani; Abdullah S Alshetaili; Muzaffar Iqbal
Journal:  Front Pharmacol       Date:  2017-11-20       Impact factor: 5.810

4.  Development, Optimization and Characterization of Eudraguard®-based Microparticles for Colon Delivery.

Authors:  Claudia Curcio; Antonio S Greco; Salvatore Rizzo; Lorena Saitta; Teresa Musumeci; Barbara Ruozi; Rosario Pignatello
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-24

5.  Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.

Authors:  Md Khalid Anwer; Muqtader Mohammad; Essam Ezzeldin; Farhat Fatima; Ahmed Alalaiwe; Muzaffar Iqbal
Journal:  Int J Nanomedicine       Date:  2019-03-01

6.  In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.

Authors:  Walaa Ebrahim Abd El Hady; Elham Abdelmonem Mohamed; Osama Abd El-Aazeem Soliman; Hassan Mohamed El-Sabbagh
Journal:  Int J Nanomedicine       Date:  2019-09-04

7.  Fabrication and evaluation of novel quercetin-conjugated Fe3O4-β-cyclodextrin nanoparticles for potential use in epilepsy disorder.

Authors:  Mona Hashemian; Maryam Ghasemi-Kasman; Shahram Ghasemi; Atefeh Akbari; Monire Moalem-Banhangi; Leila Zare; Seyed Raheleh Ahmadian
Journal:  Int J Nanomedicine       Date:  2019-08-13

Review 8.  Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications.

Authors:  Ibrahim Khalil; Wageeh A Yehye; Alaitz Etxabide Etxeberria; Abeer A Alhadi; Seyedehsara Masoomi Dezfooli; Nurhidayatullaili Binti Muhd Julkapli; Wan Jefrey Basirun; Ali Seyfoddin
Journal:  Antioxidants (Basel)       Date:  2019-12-26

Review 9.  Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies.

Authors:  Shimon Ben-Shabat; Ludmila Yarmolinsky; Daniel Porat; Arik Dahan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 10.  Drug Delivery Strategies for Curcumin and Other Natural Nrf2 Modulators of Oxidative Stress-Related Diseases.

Authors:  Nina Katarina Grilc; Matej Sova; Julijana Kristl
Journal:  Pharmaceutics       Date:  2021-12-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.